Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
A Systematic Review of Strategies to Improve Prophylaxis for Venous Thromboembolism in Hospitals
2005
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience
2010
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Long-term blood pressure telemetry in AT2 receptor-disrupted mice
2000
Interventions for enhancing medication adherence
2005
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Ultra-early evaluation of intracerebral hemorrhage
1990
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
2007
Efecto de la actuación farmacéutica en la adherencia del tratamiento farmacológico de pacientes ambulatorios con riesgo cardiovascular (Estudio EMDADER-CV-INCUMPLIMIENTO)
2011
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
1993
Prevention of VTE in Nonsurgical Patients
2012 Standout
Self-Management of Oral Anticoagulant Therapy: A Review
2004
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Interventions to Enhance Medication Adherence in Chronic Medical Conditions
2007
Mechanisms of brain injury after intracerebral haemorrhage
2005 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Prevention of Venous Thromboembolism
2004 Standout
Atrial fibrillation management: a prospective survey in ESC Member Countries
2005
Which drugs cause preventable admissions to hospital? A systematic review
2006
Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?
2007
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Prevention of Venous Thromboembolism
2008 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Preventable stroke and stroke prevention
2005
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Human genetics, animal models and computer simulations for studying hypertension☆
2004 StandoutNobel
Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes
2008
Spontaneous Intracerebral Hemorrhage
2001 Standout
Eficacia de la información al alta en la adherencia del paciente polimedicado
2011
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2004 Standout
Treatment of Patients Over 64 Years of Age With Type 2 Diabetes
2003
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
2006 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Interventions for enhancing medication adherence
2008 Standout
Risk Factors for Adverse Drug Events Among Older Adults in the Ambulatory Setting
2004
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Patients’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests
2014
Low Health Literacy and Health Outcomes: An Updated Systematic Review
2011 Standout
Interventions for enhancing medication adherence
2014 Standout
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
2007
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study.
2006
The ABCs of Measuring Intracerebral Hemorrhage Volumes
1996 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Screening Tests for Intended Medication Adherence Among the Elderly
2006
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Medication Adherence
2009 Standout
The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
2003
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Works of J Vial being referenced
Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice
2001
Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy
2004
Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic
2004
Adverse drug events as a cause of hospital admission in the elderly
2001
Improving the outcomes of anticoagulation: an evaluation of home follow‐up of warfarin initiation
2004
Educational campaign to improve the prevention of postoperative venous thromboembolism
1999
Review of management of type 2 diabetes mellitus
1998
Inhibition of platelet function by a controlled release acetylsalicylic acid formulation — Single and chronic dosing studies
1984
Doctors’ beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention
2002
ONSET AND OFFSET OF STRUCTURAL ARTERIOLAR CHANGES IN DOCA/SALT HYPERTENSION IN THE RAT
1982
The effects of different doses of some acetylsalicylic acid formulations on platelet function and bleeding times in healthy subjects
1986